- US-listed companies
- AbbVie Inc.
- Cash flow
AbbVie Inc.【ABBV】Cash flow
Market cap
$395.6B
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 212 | 241 | 282 | 353 | 365 | 421 | 430 | 753 | 692 | 671 | 747 | 911 |
| Cash from operations | 6,267 | 3,549 | 7,535 | 7,041 | 9,960 | 13,427 | 13,324 | 17,588 | 22,777 | 24,943 | 22,839 | 18,806 |
| Capital expenditures | -491 | -612 | -532 | -479 | -529 | -638 | -552 | -798 | -787 | -695 | -777 | -974 |
| Cash from investing | 879 | -926 | -12,936 | -6,074 | -274 | -1,006 | 596 | -37,557 | -2,344 | -623 | -2,009 | -20,820 |
| Payments for dividends | 2,555 | 2,661 | 3,294 | 3,717 | 4,107 | 5,580 | 6,366 | 7,716 | 9,261 | 10,043 | 10,539 | 11,025 |
| Repurchases of common stock | 320 | 652 | 7,567 | 6,033 | 1,410 | 12,014 | 629 | 978 | 934 | 1,487 | 1,972 | 1,708 |
| Proceeds from issuance of term debt, net | - | - | 20,660 | 11,627 | - | 5,963 | 31,482 | 3,000 | 1,000 | 2,000 | - | 16,963 |
| Cash from financing | -3,442 | -3,293 | 5,752 | -3,928 | -5,512 | -14,396 | 18,708 | -11,501 | -19,039 | -24,803 | -17,222 | -5,211 |
| Free cash flow | ||||||||||||
| FCF margin (%) |